Polymorphism of CD14 gene but not the mutation of TLR4 gene is associated with colorectal cancer in Chinese patients

Journal of Gastroenterology and Hepatology (Australia)

Volumn 21, Issue 1 PART1, 2006, Pages 92-97

  Guo, Qiusha ^a,b   Zhu, Jianbo ^a   Xia, Bing ^a,b  

^a ZHONGNAN HOSPITAL OF WUHAN UNIVERSITY   (China)

^b WUHAN UNIVERSITY   (China)

Author keywords

CD14; Colorectal cancer; Polymorphism; Toll like receptor 4

Indexed keywords

ASPARTIC ACID; CD14 ANTIGEN; GLYCINE; TOLL LIKE RECEPTOR 4;

ADULT; AGED; AMINO ACID SUBSTITUTION; ARTICLE; CANCER CLASSIFICATION; CANCER PATIENT; CANCER RISK; CANCER SCREENING; CHINESE; COLON ADENOCARCINOMA; COLON CARCINOGENESIS; COLORECTAL CARCINOMA; COMPARATIVE STUDY; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENE MUTATION; GENETIC ASSOCIATION; GENETIC DIFFERENCE; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MUTATIONAL ANALYSIS; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK ASSESSMENT; SCREENING TEST;

EID: 33645238579     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2005.04156.x     Document Type: Article

References (31)

1. Kojima M Morisaki T Izuhara K et al. Lipopolysaccharide increases cyclo-oxygenase-2 expression in a colon carcinoma cell line through nuclear factor-kappa B activation Oncogene 2000 19 1225 31
2. Yoshioka T Morimoto Y Iwagaki H et al. Bacterial lipopolysaccharide induces transforming growth factor beta and hepatocyte growth factor through toll-like receptor 2 in cultured human colon cancer cells JIntMedRes 2001 29 409 20
3. Ziegler-Heitbrock HW Ulevitch RJ. CD14: cell surface receptor and differentiation marker ImmunolToday 1993 14 121 5
4. Wright SD Ramos RA Tobias PS et al. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein Science 1990 249 1431 3
5. da Silva CJ Soldau K Christen U et al. Lipopolysaccharide is in close proximity to each of the proteins in its membrane receptor complex: transfer from CD14 to TLR4 and MD-2 JBiolChem 2001 276 21129 35
6. Pugin J Heumann ID Tomasz A et al. CD14 is a pattern recognition receptor Immunity 1994 1 509 16
7. Schutt C. CD14. IntJBiochemCell Biol 1999 31 545 9
8. Medzhitov R Janeway C Jr. Innate immunity NEnglJMed 2000 343 338 44
9. Frey EA Miller DS Jahr TG et al. Soluble CD14 participates in the response of cells to lipopolysaccharide JExpMed 1992 176 1665 71
10. Hubacek JA Rothe G. Pit'ha J et al. C(-260) - >T polymorphism in the promoter of the CD14 monocyte receptor gene as a risk factor for myocardial infarction Circulation 1999 99 3218 20
11. Baldini M Lohman IC Halonen M et al. A Polymorphism* in the 5′ flanking region of the CD14 gene is associated with circulating soluble CD14 levels and with total serum immunoglobulin E AmJRespirCell MolBiol 1999 20 976 83
12. Klein W Tromm A Griga T et al. A polymorphism in the CD14 gene is associated with Crohn's disease ScandJGastroenterol 2002 37 189 91
13. LeVan TD Bloom JW Bailey TJ et al. A common single nucleotide polymorphism in the CD14 promoter decreases the affinity of Sp protein binding and enhances transcriptional activity JImmunol 2001 167 5838 44
14. Arbour NC Lorenz E Schutte BC et al. TLR4 mutations are associated with endotoxin hyporesponsiveness in humans NatGenet 2000 25 187 91
15. Kiechl S Lorenz E Reindl M et al. Toll-like receptor 4 polymorphisms and atherogenesis NEnglJMed 2002 347 185 92
16. Kopp E Medzhitov R. Recognition of microbial infection by Toll-like receptors CurrOpinImmunol 2003 15 396 401
17. Okayama N Fujimura K Suehiro Y et al. Simple genotype analysis of the Asp299Gly polymorphism of the Toll-like receptor-4 gene that is associated with lipopolysaccharide hyporesponsiveness JClinLabAnal 2002 16 56 8
18. Karhukorpi J Ikaheimo I Karvonen J Karttunen R. Promoter region polymorphism of the CD14 gene (C-159T) is not associated with psoriasis vulgaris EurJImmunogenet 2002 29 57 60
19. Lichy C Meiser H Grond-Ginsbach C et al. Lipopolysaccharide receptor CD14 polymorphism and risk of stroke in a South-German population JNeurol 2002 249 821 3
20. Morre SA Murillo LS Bruggeman CA Pena AS. The role that the functional Asp299Gly polymorphism in the toll-like receptor-4 gene plays in susceptibility to Chlamydia trachomatis-associated tubal infertility JInfectDis 2003 187 341 2
21. Simmons DL Tan S Tenen DG et al. Monocyte antigen CD14 is a phospholipid anchored membrane protein Blood 1989 73 284 9
22. Schutt C Schilling T Grunwald U et al. Endotoxin-neutralizing capacity of soluble CD14 ResImmunol 1992 143 71 8
23. Goyert SM Ferrero E Rettig WJ et al. The CD14 monocyte differentiation antigen maps to a region encoding growth factors and receptors Science 1988 239 497 500
24. Zhang DE Hetherington CJ Tan S et al. Sp1 is a critical factor for the monocytic specific expression of human CD14 JBiolChem 1994 269 11425 34
25. Tapping RI Tobias PS. Soluble CD14-mediated cellular responses to lipopolysaccharide ChemImmunol 2000 74 108 21
26. Landmann R Zimmerli W Sansano S et al. Increased circulating soluble CD14 is associated with high mortality in gram-negative septic shock JInfectDis 1995 171 639 44
27. Biasucci LM Liuzzo G Angiolillo DJ et al. Pro-inflammatory response in patients with unstable angina is associated with a polymorphism in the promoter region of CD14 receptor gene EurHeart J 2001 22 Suppl. 373 39
28. Netea MG Kullberg BJ Van Der Meer JW. Lipopolysaccharide-induced production of tumour necrosis factor and interleukin-1 is differentially regulated at the receptor level: the role of CD14-dependent and CD14-independent pathways Immunology 1998 94 340 4
29. Rabehi L Irinopoulou T Cholley B et al. Gram-positive and gram-negative bacteria do not trigger monocytic cytokine production through similar intracellular pathways InfectImmun 2001 69 4590 9
30. Gregory CD Devitt A. CD14 and apoptosis Apoptosis 1999 4 11 20
31. Haziot A Ferrero E Kontgen F et al. Resistance to endotoxin shock and reduced dissemination of gram-negative bacteria in CD14-deficient mice Immunity 1996 4 407 14